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ALTERED SEXUAL MATURATION IN MALE RATS PASSIVELY IMMUNIZED AGAINST rGRF FROM 1 5 TO 4 0 DAYS OF L I F E GH d e p r i v a t i o n f o l l o w i n g p a s s i v e lmmunizatiori ( P I ) a g a l n s l r G W markedly a f f e c t s s o m a t l c yrowth i n r a t s . S l n c e i t h a s b e e r ) p o s t u l a t e d t h a t GH and p r o b a b l y IGF-I h a v e a p e r m i s s i v e r o l e on s e x u a l m a t u r a t i o n , t h e e f f e c t of GI1 d e p r i v a t i o r i on t h e c o u r s e o f
s e x u a l m a t u r a t i o n was t e s t e d . M a l e r a t s w e r e t -r e a t e d w l t h a p o t e n t a n t i -r G W serum between 1 5 and 4 0 d a y s o f l i f e ( d ) . Body w e i g h t (BW) o f t r e a t e d r a t s a v e r a q e d 7 6 . 3 % o f t h a t of c o r i t r o l r a t s a t 4 0 d and was m a x i m a l l y a f f e c t e d a t 5 0 d ( 5 6 . 9 % ) a f t e r w h i c h a g e , t r e a t e d r a t s s t a r t e d t o grow n o r m a l l y . At 4 0 and 5 0 d , plasma GH was u n d e t e c t a b l e and p l a s m a IGF-I l e v e l s a v e r a q e d 3 0 % o f t h o s e o f c o n t r o l r a t s . A t 7 0 d , GI1 & I G F -I s e c r e t i o n s were normal. At 4 0 d , t e s t e s a n d s e m i n a l v e s i c l e s o f t r e a t e d r a t s w e r e s m a l l -f o r -a g e i n a g r e e m e n t w i t h s l g n l f i c a n t l y d e c r e a s e d p l a s m a l e v e l s o f t e s t . o s t . c r o n e a n d FSH. A t 5 0 d , d e s p i t e maximum d e l a y o f s o m a t i c g r o w t h , p r o y r e s s o f s e x u a l m a t u r a t i o n w a s f o u n d t o b e a l m o s t n o r m a l . A t 4 0 a n d 5 0 d , p i t u i t a r y w e i g h t a n d c o n t e n t s of G H , FStl, and L l i were s e v e r e l y d e c r e a s e d b u t b e c a m e n o r m a l a t 7 0 d . I n c o n c l u s i o n , G H B e p r i v a t i o n m a r k e d l y a f f e c t e d s o m a t l c g r o w t i ) a n d i n d u c e d a t r a n s i e n t d e l a y o f s e x u a l m a t u r a t i o n s e c o n d a r y t o a p a r t i a l inhibition of s y n t h e s i s and r e l e a s e o f Lti & FSii. T h i s i n h i i l l t i o n o f LH & FSH s e c r e t i o n may r e s u l t from c e n t r a l i n h i b i t i o n o f GnRli s e c r e t i o n o r froni 1mpal.red development of t h e p i t u i t a r y g l a n a . 
The availability for clinical use o f sornatocrinine growth hormone releasing hormone ( G R F I brings about the possibility of treatment of growth hormone deficient children (GHD) of hypothalamic origin. We present the results of the f~r s t 6 months of treatment of G R F in 2 0 G H D children. Ten boys and 1 0 girls w i t h mean chronological age of 10.7 f2.7 yr, bone age 6.1 2.5 ..yr" and w i t h a mean growth retardation o f 4.7 f 0.6 SD were treated w i t h G R F 1 -4 4 S A N O F I b y daily ( N = 11) or thrice weekly ( N = 9) sutxutaneous injection i n doses o f 1 0 u g l k g body weight. A l l o f the c h~l d r e n were i n prepubertal stage and i n all the peak G H response t o clonidine and I'dopa provocative tests was M o w 5 nglml. Nlne patients had TSH d e f~c~e n c y and were parallely treated w i t h I'thyroxine. The G R F i.v. bolus test was performed before treatment and 2 and 6 months after initiation of treatment. I n 9 out of 2 0 patients acceleration o f growth velocity was found. Three patients reached a growth velocity o f more than 4.4 c m per yr. Growth velocity during the treatment was significantly correlated w l t h peak G H response t o G R F i.v. bolus before (r-0.6786) and during the treatment (r=0.4863 and r -0.5947, respectively). The growth velocity was greater i n younger children and i n those w i t h less advanced bone age. Acute response t o G R F was significantly greater after 6 months o f treatment than before the treatment (mean peak G H response 2.9 f 3.0 and 7.6 + 8 . l n g l m l respectively, p <0.05).
N o side effects o f the treatment were obsetved and immunolog~cal tolerance was good. We concluded that chronic administration of G R F is well tolerated and resulted i n enhanced growth i n some o f the G H D children and evoked better response of 
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In a previws work we demxlstrated that in adults timing of QUI stlrmlaticn i n relation t o the patkm of spntanems G I secretion cculd condition M r e s m . T o investigate i f there was a similar sibatLon in children,a test (5F-29,Semo 1 mcg/kg,iv bolus) was performed in 1 7 SN (@1,9F,7-11 yj and 6 0iT (3M,%,E-12 y j a t 0 9 . 3 h after an o v e m & t f a s t and 3' resting.Fmn the analysi:; of p l m Qi variations (-30',01) prior tc s t i m l a t i c n , 3 theoretical phases i n t6R were estab1ished:A)Secmtim Phase ;BjSecretion P1ateau;C)Refractory 
While it is clear that e n d o g e m tER conditicns the response t o 0U-29 m S N . l t appears t h a t sexual E R d u m r p h u n , p~n w s l y reported b y u s , m s t k g m a f t e r p w krty,because both the sexual &strlbuticn per phase and Q i peak were very sm1ar.lhe fact t h a t SN m phase C shcwed smlar respanses to those m MD m&cates that the f u n c t i d stam of t i % must be taken Into account t o nurunuze errors m &agwsls a f t e r QU1 t&zt and pcsslbly also m GRW therapy. 
The Endocrine U n i t , The Eliddleaex I l o s p i t a l , London W1 U n i t e d Kingdom.
CONTINUOUS S.C. INFUSIONS OF CLIRH ANAI.OCUE CllRll(l-29) W
NOT DESENSITIZE TIIT. SOMATOTROPII.
We have shown t h a t CHRII n d m i n l a t e r e d subcutaneously i n a p u l s a t i l e f a s h i o n i s e f f e c t i v e i n t h e treatment o f 611 d e f i c i e n y . 611 s e c r e t i o n was not augmented b y doses o f 7.5 and 15nglkglmin. W i t h 30nglkglmin s i g n i f i c a n t i n c r c n s e s i n Cll p u l s e frequency and a m p l i t u d e were achieved w i t h normal p r o f i l e s .
Doses of 60 and 120nglkglmin induced h i g h p u l s e frequency (up t o 13 pulses124 11) and we know from c l i n i c a l s t u d i e s t h a t CII n e u r o s c c r e t o r y d y s f u n c t i o n ( > 9 pulses124 11) f a i l s t o produce adequate growth. 12Onglkglmin a l s o produced v e r y h i g h GII pedhs (max 122mU/L) which f a i l e d t o r e t u r n t o t h e b a s e l i n e between pulses, an abnormal p u l s e p r o f i l e .
There has been no evidence o f d e s e n s i t i z a t i o n o f t h e h y p o t l l a l a m o -p i t u i t x y axis a t any dose o v e r one week. Wl~ellter suclt a p a t t e r n r c r l e c t s an a l t e r a t i o n i n h y p o l l~a l a n i c o r p i t u i t a r y mccl~anisms i s unknoun.ln thc p r e s e n t sludy u c i n v e s t i g a t e d GI1 response t o i.v. Gll A a f t e r Gnl (43.4 2 42.3 vs 25.0 i 17.2; 1 p> 0.2)uerc o n l y s l i g h t l y b u t n o t s i g n i r i c a n t l y Ihigher i n the bypolhyroids.No r e l a t i o n s h i p uas iaund between c i t l l c r GI1 peak or 611 A and t h y r o i d f u n c t i o n t e s t s i n b o t h groups.0ur data i n d i c a l c that. t h a t sonatotroph s c n s i v i t y t o GRi and p i t u i t a r y GI1 reserve as u c l l a r e n o t subs t a n t i a l l y impaircd i n h y p o t h y r o i d subjects.Thc subnormal GI1 s e c r e t i o n a s s o c i a t e d w i t h t h y r o i d Failurc.thcrefore.may probably r c F l c c t a hypothalamic disorder.Such c o n c l u s i o n c o n t r a s l s u i t l l t h a t OF a r e c e n t study i n h y p o t h y r o i d r a l s ( n i e g u e 2 c t a1 .J Cndocr 109.53.1986).
